Bayer

Mollie Engelhart, a MAHA-aligned farmer, hosted a retreat for pro-MAHA leaders but expressed disillusionment with the Trump administration's support for Bayer's Roundup. The administration's backing of Roundup, including an executive order labeling glyphosate-based herbicides as critical to national security, has caused tension with MAHA-aligned supporters who expected stronger action on chemical-laden food systems.

U.S. lawmakers are introducing legislation to override a Supreme Court ruling that limits consumer lawsuits against pesticide companies. The proposed amendment to FIFRA, called the People Over Poison Act, aims to restore the ability of individuals to sue companies for failing to warn about health risks. The ruling primarily benefits Bayer and Syngenta, which face numerous lawsuits over products like Roundup.

The U.S. Supreme Court ruled 7-2 that state courts cannot hold Monsanto liable for labeling issues in pesticides like Roundup, as federal law preempts such claims. The decision dismissed a $1.25 million verdict awarded to a man who claimed Roundup caused his cancer, with justices citing compliance with EPA regulations. The ruling split the court, with Justice Brett Kavanaugh writing the majority and Justice Ketanji Brown Jackson dissenting.

The Supreme Court ruled in favor of Bayer in the Roundup case, limiting future lawsuits against the company and its subsidiary Monsanto. Patti Goldman of Earthjustice discussed the decision on ChicagoLIVE.

The U.S. Supreme Court ruled 7-2 that federal law blocks state failure-to-warn lawsuits against Bayer, the parent company of Monsanto, regarding Roundup weed killer labels. The decision holds that the Federal Insecticide, Fungicide, and Rodenticide Act preempts state claims seeking cancer warnings on EPA-approved Roundup labels, marking a setback for cancer patients pursuing legal action.

A US Supreme Court ruling could protect Bayer from thousands of lawsuits linking its herbicide Roundup to cancer. Protests occurred outside the Supreme Court in Washington against the decision to drop these lawsuits.

Bayer faces numerous lawsuits over its pesticide Roundup due to not adding cancer warnings, despite US regulators opposing such a warning. A recent Supreme Court win may impact the company's potential billions in payments.

The U.S. Supreme Court ruled 7-2 that state courts cannot hold Monsanto liable for labeling issues in Roundup, dismissing a $1.25 million verdict for a man who claimed the herbicide caused his non-Hodgkin lymphoma. The decision emphasized federal law preemption under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), but faced criticism from dissenting justices over consumer protection concerns.

The Supreme Court blocked a Roundup cancer lawsuit in a 7-2 decision, ruling federal law prevents state failure-to-warn claims against Monsanto. The ruling overturned a $1.25 million jury award to John Durnell and is expected to dismiss thousands of similar lawsuits, though a $7.25 billion class-action settlement remains intact. Justices Ketanji Brown Jackson and Neil Gorsuch dissented, arguing the decision relies on a non-existent labeling requirement.

The Supreme Court blocked a lawsuit alleging Roundup weed killer causes cancer, ruling 7-2 that federal law prevents state failure-to-warn claims against Monsanto. The decision overturned a $1.25 million award to plaintiff John Durnell, while a $7.25 billion class-action settlement remains pending. Justices Ketanji Brown Jackson and Neil Gorsuch dissented, arguing the ruling was based on a non-existent labeling requirement.

The US Supreme Court ruled in favor of Bayer, blocking thousands of lawsuits alleging its Roundup weedkiller caused cancer due to inadequate warning labels. The decision supports President Donald Trump's administration but faces criticism from the 'Make America Healthy Again' movement.

The US Supreme Court ruled in favor of Bayer in Roundup cancer lawsuits. Bayer, which acquired Roundup in 2018, stated the decision benefits science and farmers. The ruling faced criticism from both Republicans and Democrats.

The U.S. Supreme Court ruled 7-2 in favor of Bayer, the maker of Roundup, blocking state court lawsuits over failure-to-warn claims about cancer risks. The decision, which aligns with federal regulatory findings, is expected to end thousands of litigation cases but faces criticism from plaintiffs' lawyers. Bayer plans to proceed with a $7.25 billion settlement to resolve remaining claims, while Missouri resident John Durnell, who developed non-Hodgkin’s lymphoma after using Roundup, was the lead plaintiff in the case.

The U.S. Supreme Court ruled 7-2 that state courts cannot hold Monsanto liable for Roundup's labeling, stating federal law preempts such claims. The decision overturned a $1.25 million award to a man who claimed Roundup caused his non-Hodgkin lymphoma, with Justice Brett Kavanaugh's majority opinion and a dissent from Justice Ketanji Brown Jackson.

The U.S. Supreme Court ruled 7-2 that state courts cannot hold Monsanto liable for labeling shortcomings in pesticides like Roundup, as federal law preempts such claims. The decision overturned a $1.25 million verdict awarded to John Durnell, who claimed Roundup caused his non-Hodgkin lymphoma, with Justice Brett Kavanaugh writing the majority opinion and Justice Ketanji Brown Jackson dissenting.

The U.S. Supreme Court ruled in favor of Monsanto (now owned by Bayer), shielding the company from state liability over its weed killer Roundup. The decision held that federal law preempts state claims regarding pesticide labeling, with Justice Kavanaugh writing the majority opinion and Justice Jackson dissenting.

The U.S. Supreme Court ruled 7-2 that state courts cannot hold Monsanto liable for labeling shortcomings in Roundup, citing federal preemption under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). The decision overturned a $1.25 million Missouri verdict awarded to John Durnell, who claimed Roundup caused his non-Hodgkin lymphoma, with Justice Brett Kavanaugh writing the majority and Justice Ketanji Brown Jackson dissenting.

The U.S. Supreme Court ruled 7-2 that federal law preempts state liability claims against Monsanto over Roundup's labeling, overturning a $1.25 million verdict awarded to a Missouri man who claimed the herbicide caused his non-Hodgkin lymphoma. The decision, with Justice Kavanaugh's majority opinion and Justice Jackson's dissent, held that the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) regulates pesticide labels, preventing states from imposing additional requirements.

The U.S. Supreme Court ruled 7-2 that state courts cannot hold companies liable for labeling shortcomings in pesticides like Monsanto's Roundup, as federal law preempts such claims. The decision overturned a $1.25 million Missouri verdict awarded to John Durnell, who claimed Roundup caused his cancer, with Justice Brett Kavanaugh writing the majority opinion and Justice Ketanji Brown Jackson dissenting.

The Supreme Court ruled 7-2 to block thousands of lawsuits against Bayer, the maker of Roundup weedkiller, citing federal regulations that do not require cancer warnings. The decision allows Bayer to proceed with a $7.25 billion class-action settlement while dismissing claims based on failure-to-warn allegations.

The US Supreme Court overturned a verdict against Bayer in a case alleging the manufacturer failed to warn about Roundup weedkiller's alleged cancer risks. The decision represents a significant legal victory for Bayer.

The Supreme Court ruled 7-2 to block thousands of lawsuits against Bayer, the maker of Roundup weedkiller, citing federal regulations that found a cancer link unlikely. The decision, a victory for Bayer, follows a case involving Missouri resident John Durnell, who was awarded $1.25 million by a jury after developing non-Hodgkin’s lymphoma from Roundup use.

Eli Lilly and Bayer criticize Germany's spending on new medicines. Pharmaceutical groups support the US's opposition to legislation aimed at lowering drug prices.

The Center for Biological Diversity sued the Trump administration for refusing to release documents related to an executive order promoting glyphosate production. The lawsuit claims the order, which delegates authority under the Defense Production Act to boost glyphosate and elemental phosphorus production, was influenced by the pesticide industry. Bayer, the sole U.S. producer of glyphosate-based herbicides, is highlighted in the case.

Bayer's shares are dependent on two upcoming court decisions following a $60 billion financial rout. The company's stock performance is closely tied to the outcomes of these legal rulings.

A coalition of chemical manufacturers and industry groups has launched a national effort since 2024 to pass 'immunity laws' shielding pesticide companies from lawsuits, despite growing evidence linking pesticides to health issues like cancer and Parkinson's disease. Over 57,000 pesticide products are registered in the U.S., and opponents argue EPA-approved labels are insufficient to protect users from undisclosed risks.

The USDA eliminated a Biden-era initiative focused on increasing seed market competition, which included experts handling farmer complaints and consulting on antitrust issues. The department later announced a partnership with DOJ to address seed industry concentration, despite having fired the team just weeks earlier. The Trump administration previously approved mergers in the seed industry, now criticized for anticompetitive practices.

The U.S. Supreme Court is set to rule on whether lawsuits can be filed against pesticide makers over cancer claims. Studies show a geographic correlation between heavy pesticide use and higher cancer rates, and agrichemical companies like Bayer face thousands of lawsuits. The Trump administration and pesticide industry have pushed for liability shield laws, while advocacy groups challenge these efforts.

Bayer’s proposed $7.25 billion Roundup settlement is challenged as unconstitutional in a legal filing, alleging it violates due process by favoring lawyers with $675 million in fees while offering minimal compensation to cancer victims. Critics argue the deal allows Bayer to continue selling glyphosate-based herbicides without cancer warnings and binds future users to the settlement terms.

Bayer has agreed to suspend loyalty programs in seed contracts for seven years, as per a U.S. Department of Justice (DOJ) agreement. The DOJ cited these provisions as 'unfair' and harmful to competition, particularly affecting farmers' prices. The company will drop requirements linking corn and soybean seed sales for the 2025 planting year.

Bayer has agreed to suspend key provisions of its seed loyalty programs for seven years, as per an agreement with the Trump administration's Department of Justice (DOJ), which labeled the provisions as unfair and harmful to competition. The DOJ cited concerns that Bayer's incentives for resellers discouraged seeking cheaper alternatives, potentially raising prices for farmers. The agreement includes dropping the requirement for resellers to meet combined corn and soybean sales targets to receive discounts.

President Donald Trump invoked the Defense Production Act to ensure domestic production of glyphosate-based herbicides, citing national security and food supply chain resilience concerns. China currently produces 50% of crop protection products, posing a risk to US food security. Domestic production aims to secure a stable supply of glyphosate, essential for agricultural productivity and food safety.

Novo Nordisk's shares rose after reporting improved earnings and guidance, driven by strong sales of its Wegovy pill. The company ticked up its adjusted sales and operating profit forecasts. This comes as a positive development for Novo Nordisk in the obesity drug market.

The 'Make America Healthy Again' (MAHA) movement succeeded in removing pesticide liability language from a House farm bill but lost support for its nominee to surgeon general. The vote showed MAHA's influence on food policy, while the withdrawal of Casey Means' nomination highlighted tensions over vaccine messaging and public health alignment.